This is an exciting opportunity to be part of the new be Ineos Oxford Institute for Antimicrobial Research (IOI) within the Department of Biology. The researcher will analyze large bacterial genome collections to identify the series of evolutionary events that underpin the acquisition of multi-drug resistance (MDR) in important pathogenic species. The successful candidate will develop and apply genome analysis pipelines to identify potentiating mutations and/or gene gains in natural MDR clone populations and identify novel genetic signatures convergently evolving with MDR. Techniques will include quantitative comparative genomics approaches such as genome-wide association studies and covariation analyses. They will hold, or be close to completion of, a postgraduate degree in a relevant subject (e.g. microbiology, bioinformatics, genomics) and have bioinformatics and genome analysis experience. They will also have interest in pathogen evolution and demonstrable enthusiasm for the project topic. While being an independent researcher able to take the initiative, they will also work closely with other researchers within the Sheppard Lab and the IOI, to integrate their work within the broader research programme. With excellent communication skills, they will be able to write for publication, present research proposals and results, engage with a wide range of stakeholders, and represent the research team at meetings and conferences.
The posts will be based at the William Dunn School, South Parks Road Oxford, OX1 3RE.
This is a full-time fixed term post until 30th April 2026 in the first instance.
The closing date for applications is 12.00 noon (GMT+1) on Tuesday 11th April, interviews are likely to be scheduled for w/c April 17th April.
The University of Oxford is committed to equality and valuing diversity. All applicants will be judged on merit, according to the selection criteria.